Mucosal Therapeutics, LLC

Other

Nova Technology Corporation

Stephen T Sonis

Edward G Fey

Overall and constituent oral mucositis assessment scale scores are generated by the use of a probe to obtain moisture measurements at a particular site. A control collects data samples. A converter produces a value for the oral mucositis assessment scale (OMAS) in response to the collected data (DPM) in accordance with a correlation defined by: 

Method and apparatus for accessing oral mucositis

The invention features a method for the treatment or prevention of mucositis in an individual undergoing or preparing to undergo cancer treatment. The method includes administering a therapeutically effective amount of an inhibitor of NF-&#x3ba;B to an individual undergoing or preparing to undergo a treatment for cancer. In certain embodiments, the inhibitor is a compound having the formula:where Rand Rare OH, and Rand Rare independently OH or H, provided that when Rand Rare both OH, Rand Rcannot be disposed ortho to one another, and when Rand Rare both OH, Rand Rcannot be disposed ortho to one another. The compounds of formula I may be cis or trans.

Treatment and prevention of mucositis in cancer patients

A method of reducing or inhibiting mucositis in a patient, which includes administering an inflammatory cytokine inhibitor or a mast cell inhibitor, or a combination thereof, is disclosed.

Methods and compositions for treating and preventing mucositis

Intervention for oral mucosal injury secondary to chemotherapy or radiation based on the inhibition in the synthesis of ceramide, blockage of its activity, or its digestion.

Growing community of inventors

Wayland, MA, United States of America

Stephen T Sonis